Benjamin Ackerman is a biostatistics leader with eight years of experience translating complex data into actionable evidence for public health and medicine. Currently Director of Real-world Biostatistics at GSK, he designs and analyzes oncology studies that bridge randomized trials and observational real-world data. He previously led simulation-based methods research at Johnson & Johnson and built clinico-imaging analytical capabilities and teams at Flatiron Health. A recent PhD from Johns Hopkins, his methodological work focuses on improving trial generalizability and comparability of real-world and trial endpoints, with applied projects spanning LGBT health, mental health, substance use, and autism. He blends academic rigor with product-facing impact—having led an FDA U01-funded effort—and is equally at home writing simulation code or steering multidisciplinary teams. Based in New York, he brings a rare mix of methodological depth and pragmatic real-world evidence delivery.
8 years of coding experience
8 years of employment as a software developer
Johns Hopkins University
Biostatistics, Biostatistics at Columbia University Mailman School of Public Health
Doctor of Philosophy (PhD) Biostatistics, Doctor of Philosophy (PhD) Biostatistics at Johns Hopkins Bloomberg School of Public Health
Contributions:116 commits, 84 pushes, 1 comment in 1 year
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Benjamin Ackerman - Principal Scientist, Biostatistics